NCT06248541

The Effect of Low-Level Laser Therapy in Carpal Tunnel Syndrome

The Effect of Low-Level Laser Therapy in Carpal Tunnel Syndrome: A Randomized, Single-Blinded, Placebo-Controlled Trial
Medical University of Graz·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Carpal Tunnel Syndrome
Drug/Device/Intervention
treatment with low-level laser therapy
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Medical University of Graz
Location
Graz, Austria
Timeline & enrollment
Phase
N/A
Start date
Aug 03, 2023
End date
Dec 31, 2025
Enrollment
40 participants
Primary outcome

Pain: at rest (Numerical Rating Scale for Pain, NRS),Pain:movement pain (Numerical Rating Scale for Pain, NRS),Pain: Night pain (Numerical Rating Scale for Pain, NRS),Health-related quality of ife (SF-36 ),Hand function (Quick-DASH),Hand function and CTS severity (Boston CTS Syndrome Questionnaire)

Summary

Carpal tunnel syndrome (CTS) is a chronic compression of the median nerve, which can lead to
 symptoms such as nocturnal pain and paresthesia in the area innervated by the median nerve.
 The affected patients also describe discomfort and hypoesthesia in the nerve supply area. Due
 to the COVID (Coronavirus disease) pandemic, CTS operations have been postponed and delayed.
 A promising and safe alternative for improving CTS-related symptoms appears to be
 non-invasive, non-thermal low-level-laser therapy. As a possible conservative, alternative
 method, low-level-laser therapy has the potential to enable patients with CTS to improve
 their disease-related symptoms or at least to alleviate the symptoms until the indicated CTS
 operation (carpal tunnel release).
 
 The aim of this randomized, single-blind, placebo-controlled clinical trial is to investigate
 the influence of 3 weeks of low-level-laser therapy on the symptoms typical of CTS in
 patients with surgery-indicated carpal tunnel syndrome and its influence on quality of life.

ICD-10 classifications
Carpal tunnel syndromeTarsal tunnel syndromeArthrosis of first carpometacarpal joint, unspecifiedArthrosis of first carpometacarpal jointOther specified disorders of synovium and tendon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06248541
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06248541 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Graz and is currently Recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.